High-Value Federal Grants ($5M+) — February 22, 2026

$11.56B in cost-plus contracts to Amentum/Jacobs for Hanford/West Valley through 2026 locks in ~$7B remaining obligations post-outlays.

$1.52B in shipbuilding and base rebuilds to 2027 for Eastern Shipbuilding/AECOM JV, with $311M options and $429M subawards.

$1.38B across CMS/NIH/BARDA to Serco/Leidos/Cerus through 2028, with 50%+ outlays on some signaling execution momentum.

$445M potential (incl. $287M options) to Booz Allen/Leidos/CACI through 2029 for IT/eng services at key sites.

Low outlays vs. obligations (e.g., $448k/$1.4B on shipbuilding; $0 on CACI) flag potential delays in long-term contracts.

Near-term expirations (Hanford 2025; CMS 2023; Booz 2025) risk recompetition under full/open rules.

Firm-fixed-price structures expose to overruns; heavy subawards (e.g., $429M/709 on shipbuilding) add dependency.

$1B+ in unexercised options across contracts (e.g., $287M CACI; $311M Eastern; $143M Booz).

Follow-on potential post-2025/26 ends in DOE env mgmt and Coast Guard rebuilds (Phase 2 implies more).

~$1B remaining outlays on HHS R&D (e.g., $59M Leidos; $100M+ Cerus).

77% of value in cost-plus waste/tank farm mgmt through 2026 provides backlog stability amid ongoing cleanup mandates.

$1.5B in OPC ships and base rebuilds to 2027 under full competition highlights fleet/infra upgrade cycle.

Multi-year awards to 2028 in eligibility, pathogen tech, and biomed R&D signal sustained post-pandemic priorities.

{"entity"=>"Amentum (Hanford contract)", "reason"=>"$10.6B obligation ends 2025-02-23; $7B remaining post-outlay at risk of recompetition.", "trigger"=>"DOE recompete RFP or extension award"}

{"entity"=>"Eastern Shipbuilding (OPC)", "reason"=>"$1.4B with minimal outlay flags execution risks over 13-year span.", "trigger"=>"outlay acceleration >10% QoQ or milestone delays"}

{"entity"=>"CACI (GSA engineering)", "reason"=>"$415M potential via options to 2029; $0 outlay early indicator.", "trigger"=>"first option exercise unlocking $100M+"}